Sheldon Koenig, Esperion CEO
Esperion gets out the budget ax, chopping 170 staffers as its big drug launch sputters
Esperion’s executive team spent years insisting that they had found the sweet spot in the market for their cholesterol drug. But that strategy has soured …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
